A randomised, double-blind, parallel arm, placebo controlled trial to determine the effect of vildagliptin used in combination with insulin therapy on glycaemic variability in adults with type 1 diabetes mellitus of at least 2 years duration.

Status: Completed

Phase of Trial: Phase III/IV

Latest Information Update: 27 Feb 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Vildagliptin (Primary) ; Insulin
Indications Type 1 diabetes mellitus
Focus Registrational; Therapeutic Use
Acronyms VITAL

Most Recent Events

27 Feb 2018 Status changed from active, no longer recruiting to completed.
24 Mar 2017 Planned number of patients changed from 60 to 72.
24 Mar 2017 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com

Welcome to AdisInsight